ERO COPPER CORP (ERO) Fundamental Analysis & Valuation

NYSE:ERO • CA2960061091

Current stock price

27.05 USD
-1.34 (-4.72%)
Last:

This ERO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ERO Profitability Analysis

1.1 Basic Checks

  • ERO had positive earnings in the past year.
  • ERO had a positive operating cash flow in the past year.
  • ERO had positive earnings in 4 of the past 5 years.
  • ERO had a positive operating cash flow in each of the past 5 years.
ERO Yearly Net Income VS EBIT VS OCF VS FCFERO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • ERO's Return On Assets of 13.71% is amongst the best of the industry. ERO outperforms 90.18% of its industry peers.
  • With an excellent Return On Equity value of 28.19%, ERO belongs to the best of the industry, outperforming 93.25% of the companies in the same industry.
  • The Return On Invested Capital of ERO (13.17%) is better than 84.05% of its industry peers.
  • ERO had an Average Return On Invested Capital over the past 3 years of 8.91%. This is significantly below the industry average of 58.80%.
  • The last Return On Invested Capital (13.17%) for ERO is above the 3 year average (8.91%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.71%
ROE 28.19%
ROIC 13.17%
ROA(3y)5.05%
ROA(5y)10.57%
ROE(3y)9.36%
ROE(5y)19.62%
ROIC(3y)8.91%
ROIC(5y)15.07%
ERO Yearly ROA, ROE, ROICERO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

1.3 Margins

  • ERO's Profit Margin of 33.56% is amongst the best of the industry. ERO outperforms 91.41% of its industry peers.
  • In the last couple of years the Profit Margin of ERO has grown nicely.
  • ERO's Operating Margin of 34.57% is fine compared to the rest of the industry. ERO outperforms 79.14% of its industry peers.
  • In the last couple of years the Operating Margin of ERO has declined.
  • ERO's Gross Margin of 43.99% is fine compared to the rest of the industry. ERO outperforms 74.23% of its industry peers.
  • In the last couple of years the Gross Margin of ERO has declined.
Industry RankSector Rank
OM 34.57%
PM (TTM) 33.56%
GM 43.99%
OM growth 3Y4.33%
OM growth 5Y-5.81%
PM growth 3Y12.01%
PM growth 5Y16.08%
GM growth 3Y0.07%
GM growth 5Y-5.39%
ERO Yearly Profit, Operating, Gross MarginsERO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ERO Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ERO is still creating some value.
  • ERO has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ERO has more shares outstanding
  • The debt/assets ratio for ERO has been reduced compared to a year ago.
ERO Yearly Shares OutstandingERO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ERO Yearly Total Debt VS Total AssetsERO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • ERO has an Altman-Z score of 3.22. This indicates that ERO is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of ERO (3.22) is comparable to the rest of the industry.
  • The Debt to FCF ratio of ERO is 5.61, which is a neutral value as it means it would take ERO, 5.61 years of fcf income to pay off all of its debts.
  • ERO's Debt to FCF ratio of 5.61 is fine compared to the rest of the industry. ERO outperforms 69.33% of its industry peers.
  • ERO has a Debt/Equity ratio of 0.60. This is a neutral value indicating ERO is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.60, ERO is doing worse than 76.07% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 5.61
Altman-Z 3.22
ROIC/WACC1.07
WACC12.3%
ERO Yearly LT Debt VS Equity VS FCFERO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

2.3 Liquidity

  • ERO has a Current Ratio of 1.06. This is a normal value and indicates that ERO is financially healthy and should not expect problems in meeting its short term obligations.
  • ERO's Current ratio of 1.06 is on the low side compared to the rest of the industry. ERO is outperformed by 81.60% of its industry peers.
  • ERO has a Quick Ratio of 1.06. This is a bad value and indicates that ERO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ERO has a Quick ratio of 0.63. This is amonst the worse of the industry: ERO underperforms 83.44% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.63
ERO Yearly Current Assets VS Current LiabilitesERO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ERO Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 171.79% over the past year.
  • Measured over the past years, ERO shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.14% on average per year.
  • Looking at the last year, ERO shows a very strong growth in Revenue. The Revenue has grown by 67.11%.
  • ERO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.38% yearly.
EPS 1Y (TTM)171.79%
EPS 3Y32.57%
EPS 5Y11.14%
EPS Q2Q%511.76%
Revenue 1Y (TTM)67.11%
Revenue growth 3Y22.61%
Revenue growth 5Y19.38%
Sales Q2Q%161.35%

3.2 Future

  • The Earnings Per Share is expected to decrease by -1.37% on average over the next years.
  • ERO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.45% yearly.
EPS Next Y84.39%
EPS Next 2Y42.92%
EPS Next 3Y24.15%
EPS Next 5Y-1.37%
Revenue Next Year53.11%
Revenue Next 2Y25.23%
Revenue Next 3Y14.8%
Revenue Next 5Y4.45%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ERO Yearly Revenue VS EstimatesERO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
ERO Yearly EPS VS EstimatesERO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

9

4. ERO Valuation Analysis

4.1 Price/Earnings Ratio

  • ERO is valuated correctly with a Price/Earnings ratio of 12.76.
  • Compared to the rest of the industry, the Price/Earnings ratio of ERO indicates a rather cheap valuation: ERO is cheaper than 94.48% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of ERO to the average of the S&P500 Index (27.95), we can say ERO is valued rather cheaply.
  • ERO is valuated cheaply with a Price/Forward Earnings ratio of 6.92.
  • Based on the Price/Forward Earnings ratio, ERO is valued cheaply inside the industry as 92.64% of the companies are valued more expensively.
  • ERO is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.76
Fwd PE 6.92
ERO Price Earnings VS Forward Price EarningsERO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 81.60% of the companies in the same industry are more expensive than ERO, based on the Enterprise Value to EBITDA ratio.
  • ERO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ERO is cheaper than 82.21% of the companies in the same industry.
Industry RankSector Rank
P/FCF 25.03
EV/EBITDA 9
ERO Per share dataERO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • ERO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of ERO may justify a higher PE ratio.
  • A more expensive valuation may be justified as ERO's earnings are expected to grow with 24.15% in the coming years.
PEG (NY)0.15
PEG (5Y)1.14
EPS Next 2Y42.92%
EPS Next 3Y24.15%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ERO Dividend Analysis

5.1 Amount

  • ERO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ERO Fundamentals: All Metrics, Ratios and Statistics

ERO COPPER CORP

NYSE:ERO (4/21/2026, 1:44:01 PM)

27.05

-1.34 (-4.72%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-05
Earnings (Next)05-04
Inst Owners72.42%
Inst Owner Change1.11%
Ins Owners5.86%
Ins Owner ChangeN/A
Market Cap2.82B
Revenue(TTM)785.84M
Net Income(TTM)263.72M
Analysts74
Price Target36.27 (34.09%)
Short Float %3.17%
Short Ratio2.09
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-22.39%
Min EPS beat(2)-43.87%
Max EPS beat(2)-0.91%
EPS beat(4)2
Avg EPS beat(4)1.14%
Min EPS beat(4)-43.87%
Max EPS beat(4)38.12%
EPS beat(8)4
Avg EPS beat(8)0.8%
EPS beat(12)5
Avg EPS beat(12)-1.14%
EPS beat(16)5
Avg EPS beat(16)-10.65%
Revenue beat(2)1
Avg Revenue beat(2)-4.91%
Min Revenue beat(2)-19.98%
Max Revenue beat(2)10.15%
Revenue beat(4)1
Avg Revenue beat(4)-8.99%
Min Revenue beat(4)-19.98%
Max Revenue beat(4)10.15%
Revenue beat(8)2
Avg Revenue beat(8)-9.05%
Revenue beat(12)3
Avg Revenue beat(12)-7.71%
Revenue beat(16)4
Avg Revenue beat(16)-8.04%
PT rev (1m)4.47%
PT rev (3m)27.29%
EPS NQ rev (1m)-19%
EPS NQ rev (3m)-20.96%
EPS NY rev (1m)-4.06%
EPS NY rev (3m)1.92%
Revenue NQ rev (1m)0.19%
Revenue NQ rev (3m)14.32%
Revenue NY rev (1m)-1.08%
Revenue NY rev (3m)4.28%
Valuation
Industry RankSector Rank
PE 12.76
Fwd PE 6.92
P/S 3.59
P/FCF 25.03
P/OCF 7.14
P/B 3.02
P/tB 3.02
EV/EBITDA 9
EPS(TTM)2.12
EY7.84%
EPS(NY)3.91
Fwd EY14.45%
FCF(TTM)1.08
FCFY4%
OCF(TTM)3.79
OCFY14.01%
SpS7.54
BVpS8.97
TBVpS8.97
PEG (NY)0.15
PEG (5Y)1.14
Graham Number20.6866 (-23.52%)
Profitability
Industry RankSector Rank
ROA 13.71%
ROE 28.19%
ROCE 16.33%
ROIC 13.17%
ROICexc 14.06%
ROICexgc 14.06%
OM 34.57%
PM (TTM) 33.56%
GM 43.99%
FCFM 14.34%
ROA(3y)5.05%
ROA(5y)10.57%
ROE(3y)9.36%
ROE(5y)19.62%
ROIC(3y)8.91%
ROIC(5y)15.07%
ROICexc(3y)9.49%
ROICexc(5y)18.57%
ROICexgc(3y)9.49%
ROICexgc(5y)18.57%
ROCE(3y)11.05%
ROCE(5y)18.68%
ROICexgc growth 3Y-0.12%
ROICexgc growth 5Y-16.92%
ROICexc growth 3Y-0.12%
ROICexc growth 5Y-16.92%
OM growth 3Y4.33%
OM growth 5Y-5.81%
PM growth 3Y12.01%
PM growth 5Y16.08%
GM growth 3Y0.07%
GM growth 5Y-5.39%
F-Score8
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 5.61
Debt/EBITDA 1.45
Cap/Depr 244.1%
Cap/Sales 35.94%
Interest Coverage 6.36
Cash Conversion 102%
Profit Quality 42.73%
Current Ratio 1.06
Quick Ratio 0.63
Altman-Z 3.22
F-Score8
WACC12.3%
ROIC/WACC1.07
Cap/Depr(3y)395.05%
Cap/Depr(5y)414.26%
Cap/Sales(3y)71.83%
Cap/Sales(5y)64.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)171.79%
EPS 3Y32.57%
EPS 5Y11.14%
EPS Q2Q%511.76%
EPS Next Y84.39%
EPS Next 2Y42.92%
EPS Next 3Y24.15%
EPS Next 5Y-1.37%
Revenue 1Y (TTM)67.11%
Revenue growth 3Y22.61%
Revenue growth 5Y19.38%
Sales Q2Q%161.35%
Revenue Next Year53.11%
Revenue Next 2Y25.23%
Revenue Next 3Y14.8%
Revenue Next 5Y4.45%
EBIT growth 1Y124.57%
EBIT growth 3Y27.92%
EBIT growth 5Y12.45%
EBIT Next Year151.41%
EBIT Next 3Y35.63%
EBIT Next 5Y13.82%
FCF growth 1Y158.65%
FCF growth 3YN/A
FCF growth 5Y20.15%
OCF growth 1Y171.72%
OCF growth 3Y40.2%
OCF growth 5Y19.4%

ERO COPPER CORP / ERO Fundamental Analysis FAQ

What is the fundamental rating for ERO stock?

ChartMill assigns a fundamental rating of 6 / 10 to ERO.


What is the valuation status of ERO COPPER CORP (ERO) stock?

ChartMill assigns a valuation rating of 9 / 10 to ERO COPPER CORP (ERO). This can be considered as Undervalued.


Can you provide the profitability details for ERO COPPER CORP?

ERO COPPER CORP (ERO) has a profitability rating of 7 / 10.


What is the financial health of ERO COPPER CORP (ERO) stock?

The financial health rating of ERO COPPER CORP (ERO) is 4 / 10.